The opioid antagonist naltrexone decreases seizure-like activity in genetic and chemically induced epilepsy models.
Morgan L SturgeonRachel LangtonShaunik SharmaRobert A CornellJoseph GlykysAlexander G BassukPublished in: Epilepsia open (2021)
Our data reveal that naltrexone has anticonvulsive properties and is a candidate drug for seizure treatment.